Barely Significant
← all excerpts

Efficacy of <sup>177</sup>Lu-PSMA-617 Therapy in mCRPC Patients with Liver Metastases: Insights into Survival Outcomes and Predictors of Response.

Biomedicines · 2025 · PMC11939846 · PMID 40149546

Europe PMCDOI
1
hedged sentence
0.1030
closest p · 2.1× alpha
0.1030
boldest claim

The sentences

did not reach statistical significancep = 0.103not close (p > 0.1)
Survival analysis revealed that 20% of patients in the progressive group had died, whereas no deaths were reported in the partial regressive group, although this difference did not reach statistical significance ( p = 0.103).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.